TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A randomized trial of 61 healthy adults found that a daily multi-ingredient supplement was associated with improved endothelial function, reduced arterial stiffness and lower systolic blood pressure after six months. Only 43 participants completed both visits, and the study did not measure heart attacks, strokes or other cardiovascular events, so the findings do not establish that the supplement prevents disease.
A six-month randomized trial found that healthy adults taking a daily supplement combining vitamins, minerals, amino acids and plant-derived compounds had improved measures of blood-vessel function, lower arterial stiffness and a reduction in systolic blood pressure. The small study, published in European Heart Journal Open, measured vascular indicators rather than heart attacks, strokes or other cardiovascular events, so it does not show that the supplement prevents disease.
Researchers at the University of Surrey assigned 61 healthy adults to take either the multi-component nutritional powder or a similar-looking powder without active ingredients. Participants took their assigned product daily for six months. Forty-three people completed both study visits and were included in the primary analysis. The researchers assessed vascular measures at the start and end of the study, and also measured responses one hour after the first dose.
After six months, the supplement group showed a significant improvement in endothelial function, a measure of how well the inner lining of blood vessels works. Endothelial function changed little in the control group. The supplement group also had a significant reduction in arterial stiffness, while stiffness increased in the control group. Systolic blood pressure fell significantly in the intervention group, with a smaller reduction in the control group. The report found no significant between-group difference in diastolic blood pressure after the intervention.
The researchers reported that blood lipid levels were comparable between the groups after six months. An estimated 10-year risk of a first atherosclerotic cardiovascular disease event fell slightly in the supplement group and rose in the control group. The study authors attributed that difference primarily to the systolic blood pressure change; the estimate was not a count of actual events. The trial also reported improved endothelial function one hour after the first dose, but that short-term measure does not establish a lasting clinical benefit.
What the Vascular Measures Show
Blood-vessel function, arterial stiffness and blood pressure are relevant indicators of cardiovascular health, and changes in these measures can help researchers evaluate possible interventions. The results offer a signal that a combination targeting several biological pathways may affect more than one vascular measure in healthy adults. That is of interest because earlier work has often examined individual compounds, while evidence for multi-ingredient supplements in people remains limited.
However, these findings are intermediate measures, not proof of reduced disease. The trial did not follow participants long enough or include enough people to determine whether taking the powder lowers the likelihood of a heart attack, stroke or cardiovascular death. It also does not establish that the supplement is suitable for everyone or that it should replace established care. Readers considering supplements for health reasons should discuss decisions with a qualified health professional, particularly if they have medical conditions or take medication.
Products Worth Considering
Instant Pot Pro 6-Quart 10-in-1 Electric Pressure Cooker
Cuisinart DGB-400NAS 12-Cup Automatic Grind & Brew Coffee Maker
Instant Pot RIO Wide 7.5-Quart 7-in-1 Electric Pressure Cooker
As an affiliate, we earn on qualifying purchases.
Why Researchers Tested a Combination
Vascular aging involves gradual changes in blood-vessel structure and function. The report describes endothelial dysfunction, increased arterial stiffness and elevated blood pressure as relevant markers. It also outlines processes including oxidative stress, inflammation, mitochondrial dysfunction and changes in nitric oxide availability as possible contributors.
Some nutrients and plant-derived compounds have been studied for effects on aspects of vascular health, but the report says most research has focused on compounds individually. A product combining ingredients that act on different pathways could, in theory, have complementary effects. Whether that translates into a meaningful health benefit in people remains an open question. The Surrey trial was designed to add human evidence, but its small sample and six-month duration limit the conclusions that can be drawn.
What the Trial Cannot Establish
The supplied report does not list the supplement’s full ingredient amounts, the size of each change in the measured outcomes, or detailed information about adverse effects. Those details matter for judging the scale of the findings, comparing the product with other interventions and evaluating safety. The report says 43 of 61 participants were included in the primary analysis, but does not provide a full account here of why the remaining participants did not complete both visits.
It is also unclear whether the changes persist beyond six months or apply to people with existing cardiovascular disease, older adults specifically, or populations with different health profiles. The trial did not assess actual cardiovascular events. Its estimated risk calculation used factors including age, sex, blood pressure, smoking status and cholesterol; the report says the observed group difference was driven mainly by systolic pressure, not by a measured difference in event rates.
Larger Trials Needed to Test Outcomes
The report says the findings require larger and longer clinical trials. Further studies would need to clarify the size and durability of changes, report the supplement’s formulation and safety findings in detail, and include a broader range of participants. To determine whether the product prevents cardiovascular disease, researchers would also need to assess clinical outcomes over a longer period rather than relying only on blood pressure and vascular measurements.
Until such evidence is available, the study is best read as an early clinical signal about a multi-ingredient supplement, not as a recommendation to take it. The immediate next step is confirmation in more participants and, eventually, research that can test whether changes in these markers lead to fewer cardiovascular events.
Key Questions
What did the supplement trial find?
The trial reported improved endothelial function, reduced arterial stiffness and lower systolic blood pressure in the supplement group after six months. It did not show that the supplement prevents heart attacks or strokes.
How many people took part?
Sixty-one healthy adults were assigned to the supplement or control group. Forty-three completed both study visits and were included in the primary analysis.
Did the study measure heart attacks or strokes?
No. The researchers measured vascular indicators and estimated 10-year cardiovascular risk. The study did not assess actual heart attacks, strokes or other cardiovascular events.
Does the study show people should take the supplement?
No. A small trial cannot establish broad effectiveness or suitability, and the supplied report does not provide the full ingredient amounts or detailed safety information. People considering supplements should discuss them with a qualified health professional.
Source: news-medical.net
